A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult Participants
Clinical trial NCT05236231 · COMPLETED
Trial details
- NCT number
- NCT05236231
- Sponsor
- Actelion
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-04
- Primary completion
- 2022-05-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.